Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 56 | 56 | 55 | 55 | 58 |
| Accounts receivable | -22 | 299 | -368 | -96 | 63 |
| Other Working Capital | 1,387 | 552 | -828 | -1,035 | 6,645 |
| Other Operating Activity | -5,429 | -7,292 | -4,932 | -6,008 | -9,355 |
| Operating Cash Flow | $-4,007 | $-6,386 | $-6,073 | $-7,084 | $-2,589 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -13 | 0 | 0 | -13 |
| Investing Cash Flow | $0 | $-13 | $0 | $0 | $-13 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -13 | -13 | -13 | -13 | -13 |
| Common Stock Issued | 62,081 | 0 | N/A | N/A | 0 |
| Other Financing Activity | -2,813 | 2,345 | 20,802 | 11,076 | 94 |
| Financing Cash Flow | $59,254 | $2,332 | $20,789 | $11,063 | $81 |
| Beginning Cash Position | 28,652 | 32,719 | 18,004 | 14,025 | 16,547 |
| End Cash Position | 83,899 | 28,652 | 32,719 | 18,004 | 14,025 |
| Net Cash Flow | $55,247 | $-4,067 | $14,715 | $3,979 | $-2,521 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,007 | -6,386 | -6,073 | -7,084 | -2,589 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -13 |
| Free Cash Flow | -4,007 | -6,386 | -6,073 | -7,084 | -2,602 |